Regeneron Pharmaceuticals, Inc.(REGN)
$982.29▲1.48%
Market is closed - opens 7 PM, 20 May 2024
Insights
- Regeneron Pharmaceuticals, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Regeneron Pharmaceuticals, Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Regeneron Pharmaceuticals, Inc. stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Regeneron Pharmaceuticals, Inc. stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 64.04 | Sell |
Stochastic | 93.58, 88.1 | Neutral |
Ultimate Oscillator | 62.79 | Neutral |
Stochastic Relative Strength Index | 83.94, 89.42 | Sell |
Moving Average Convergence Divergence | 14.48, 8.85 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 971.63 | Buy |
20 | 939.27 | Sell |
50 | 942.81 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 966.77 | Buy |
20 | 952.56 | Buy |
50 | 942.63 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 970.66 | Neutral |
20 | 933.41 | Buy |
50 | 939.57 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 984.16 | Buy |
20 | 969.41 | Buy |
50 | 951.75 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 986.19 | Buy |
20 | 985.38 | Buy |
50 | 949.51 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 985.94 |
Resistance L2 | 982.12 |
Resistance L1 | 975.05 |
Pivot Point | 971.23 |
Support L1 | 964.16 |
Support L2 | 960.34 |
Support L3 | 953.27 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.